Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/120642
Title: | Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort : an Epi-IBD study |
Authors: | Burisch, Johan Katsanos, Konstantinos H. Christodoulou, Dimitrios K. Barros, Luisa Magro, Fernando Pedersen, Natalia Kjeldsen, Jens Vegh, Zsuzsanna Lakatos, Peter L. Eriksson, Carl Halfvarson, Jonas Fumery, Mathurin Gower-Rousseau, Corinne Brinar, Marko Čuković-Čavka, Silvija Nikulina, Inna Belousova, Elena Myers, Sally Sebastian, Shaji Kiudelis, Gediminas Kupcinskas, Limas Schwartz, Doron Odes, Selwyn Kaimakliotis, Ioannis P. Valpiani, Daniela D’Incà, Renata Salupere, Riina Chetcuti Zammit, Stefania Ellul, Pierre Duricova, Dana Bortlik, Martin Goldis, Adrian Kievit, Hendrika Adriana Linda Toca, Alina Turcan, Svetlana Midjord, Jóngerð Nielsen, Kári Rubek Winther Andersen, Karina Andersen, Vibeke Misra, Ravi Arebi, Naila Oksanen, Pia Collin, Pekka de Castro, Luisa Hernandez, Vicent Langholz, Ebbe Munkholm, Pia |
Authors: | Epi-IBD Group |
Keywords: | Inflammatory bowel diseases Ulcerative colitis Crohn's disease Surgery Prognosis Therapeutics Biologicals |
Issue Date: | 2019 |
Publisher: | Oxford University Press |
Citation: | Burisch, J., Katsanos, K. H., Christodoulou, D. K., Barros, L., Magro, F., Pedersen, N.,...Epi-IBD Group. (2019). Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort—an Epi-IBD study. Journal of Crohn's and Colitis, 13(2), 198-208. |
Abstract: | Background and Aims: Few population-based cohort studies have assessed the disease course of ulcerative colitis [UC] in the era of biological therapy and widespread use of immunomodulators. The aim of this study was to assess the 5-year outcome and disease course of patients with UC in the Epi-IBD cohort. Methods: In a prospective, population-based inception cohort of unselected patients with UC, patients were followed up from the time of their diagnosis, which included the collection of their clinical data, demographics, disease activity, medical therapy, and rates of surgery, cancers, and deaths. Associations between outcomes and multiple covariates were analysed by Cox regression analysis. Results: A total of 717 patients were included in the study. During follow-up, 43 [6%] patients underwent a colectomy and 163 [23%] patients were hospitalised. Of patients with limited colitis [distal to the left flexure], 90 [21%] progressed to extensive colitis. In addition, 92 [27%] patients with extensive colitis experienced a regression in disease extent, which was associated with a reduced risk of hospitalisation (hazard ratio [HR]: 0.5 95% CI: 0.3–0.8]. Overall, patients were treated similarly in both geographical regions; 80 [11%] patients needed biological therapy and 210 [29%] patients received immunomodulators. Treatment with immunomodulators was found to reduce the risk of hospitalisation [HR: 0.5 95% CI: 0.3–0.8]. Conclusions: Although patients in this population-based cohort were treated more aggressively with immunomodulators and biological therapy than in cohorts from the previous two decades, their disease outcomes, including colectomy rates, were no different. However, treatment with immunomodulators was found to reduce the risk of hospitalisation. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/120642 |
Appears in Collections: | Scholarly Works - FacM&SMed |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Natural_disease_course_of_ulcerative_colitis_during_the_first_five_years_of_follow_up_in_a_European_population_based_inception_cohort_an_Epi_IBD_study_2019.pdf | 383.34 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.